Hualan Biological Engineering Inc

002007

Company Profile

  • Business description

    Hualan Biological Engineering Inc is a China-based biopharmaceutical company. It is engaged in the research, development, production, and commercialization of plasma products, viral vaccines, bacterial vaccines, recombinant proteins, and other biologics. The plasma products offered by the company include Human albumin, Human fibrinogen, Human tetanus immunoglobulin, and others. The vaccine products include Recombinant hepatitis B vaccine, Inactivated influenza vaccine, and others. It also offers gene products such as Monoclonal Antibodies for tumor, autoimmune diseases, infectious diseases, transplant rejection, and Recombinant monoclonal antibodies.

  • Contact

    No. 1, Hualan Avenue
    Henan Province
    Xinxiang453003
    CHN

    T: +86 3733559989

    http://www.hualanbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    4,012

Stocks News & Analysis

stocks

Meta earnings: Strong end to 2025 as AI monetization begins to show

Investors please with latest results.
stocks

Why doesn’t the market like the earnings from this US tech giant?

Good quarter with AI demand ramping.
stocks

Our Tesla fair value increases meaningfully

Progress on Robotaxi and Optimus shows real world AI growth.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,164.8094.40-1.02%
CAC 408,126.5355.170.68%
DAX 4024,538.81229.350.94%
Dow JONES (US)48,892.47179.09-0.36%
FTSE 10010,223.5451.780.51%
HKSE27,387.11580.98-2.08%
NASDAQ23,461.82223.30-0.94%
Nikkei 22553,322.8552.75-0.10%
NZX 50 Index13,423.1874.570.56%
S&P 5006,939.0329.98-0.43%
S&P/ASX 2008,869.1086.00-0.96%
SSE Composite Index4,117.9540.04-0.96%

Market Movers